Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JAMES M ROONEY

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1588638464
CMS profile
253333
Location
METAIRIE, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$1,796.17

131 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,784.91 129
Education $11.26 2

By paying entity

PY2019 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 131 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JAMES M ROONEY

NPI 1588638464 · CMS profile ID 253333

Allopathic & Osteopathic Physicians / Internal Medicine

METAIRIE, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 131 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1588638464?year=2019&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JAMES M ROONEY, NPI 1588638464, CMS profile ID 253333. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 131 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1588638464?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JAMES M ROONEY, NPI 1588638464, CMS profile ID 253333. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 131 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1588638464?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JAMES M ROONEY, NPI 1588638464, CMS profile ID 253333, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 131 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1588638464?year=2019&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

131 matching records · $1,796.17 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 131 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 131.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $20.7008/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681719865 CMS
Janssen Pharmaceuticals, Inc $23.7907/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659246131 CMS
Amgen Inc. $17.6307/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662445411 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6.9907/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681778283 CMS
Shire North American Group Inc $17.7307/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637906303 CMS
Allergan Inc. $12.3507/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671040149 CMS
Radius Health, Inc. $25.6307/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683961843 CMS
Novo Nordisk Inc $22.0307/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 674487605 CMS
Amgen Inc. $12.9907/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662445403 CMS
AstraZeneca Pharmaceuticals LP $11.0707/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685104553 CMS
Janssen Pharmaceuticals, Inc $13.8306/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659246127 CMS
Takeda Pharmaceuticals U.S.A., Inc. $9.4606/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682091021 CMS
Merck Sharp & Dohme Corporation $15.2606/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695663709 CMS
Novo Nordisk Inc $17.5006/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 674448013 CMS
AstraZeneca Pharmaceuticals LP $19.4306/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685209587 CMS
Lilly USA, LLC $13.8106/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657875857 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.3506/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681954659 CMS
Lilly USA, LLC $16.9906/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657875859 CMS
Janssen Pharmaceuticals, Inc $5.2605/22/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659246119 CMS
Janssen Pharmaceuticals, Inc $23.1505/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659246121 CMS
PFIZER INC. $3.8305/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673245713 CMS
Lilly USA, LLC $17.1105/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657879287 CMS
Amgen Inc. $15.2805/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662445359 CMS
Radius Health, Inc. $12.7605/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683961825 CMS
Amgen Inc. $16.5404/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662445355 CMS
Janssen Pharmaceuticals, Inc $16.6604/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659246117 CMS
PFIZER INC. $6.8304/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673242621 CMS
AstraZeneca Pharmaceuticals LP $17.7004/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685326285 CMS
Novo Nordisk Inc $13.7004/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669539647 CMS
E.R. Squibb & Sons, L.L.C. $13.7404/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651293689 CMS
Novo Nordisk Inc $10.5604/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669539649 CMS
Novo Nordisk Inc $2.0604/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682484653 CMS
Novo Nordisk Inc $1.5604/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682484659 CMS
Radius Health, Inc. $21.4104/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683961819 CMS
Merck Sharp & Dohme Corporation $14.2604/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695470945 CMS
Janssen Pharmaceuticals, Inc $14.5403/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659246115 CMS
PFIZER INC. $18.2803/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671915397 CMS
PFIZER INC. $1.9703/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673242425 CMS
Amgen Inc. $7.6303/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662445401 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.3003/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682090187 CMS
Novo Nordisk Inc $14.1603/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669481075 CMS
Merck Sharp & Dohme Corporation $13.6703/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695908933 CMS
Lilly USA, LLC $14.2103/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657868975 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3.8303/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681940185 CMS
AstraZeneca Pharmaceuticals LP $17.6803/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685996669 CMS
Novo Nordisk Inc $6.0703/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682484639 CMS
Shire North American Group Inc $22.3103/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637906301 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.6603/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700388081 CMS
Novo Nordisk Inc $17.6703/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669481073 CMS
Novo Nordisk Inc $1.7203/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682484646 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,796.17 131
PY2020 $1,349.17 85
PY2021 $1,445.36 86
PY2022 $1,508.21 92
PY2023 $1,202.47 74
PY2024 $116.08 6
PY2025 $182.65 10

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2019 Recipient $6,242.00 1
PY2019 Principal investigator $8,059.00 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Eli Lilly and Company $7,996.00 03/18/2019 Non-covered Recipient Entity
US ONCOLOGY RESEARCH LLC
A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER No dispute reported 06/30/2026 654298847
Recipient Eli Lilly and Company $6,242.00 02/26/2019 Covered Recipient Physician A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER No dispute reported 06/30/2026 654282175
Principal investigator 1 Eli Lilly and Company $63.00 02/04/2019 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE LLC
A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER No dispute reported 06/30/2026 654295365